Recent observations indicate that the induction of certain antibody responses may aide the clearance of self-antigens associated with cell debris, aiding in the sequestration and disposal of """"""""cellular garbage"""""""". We will test the mechanistic hypothesis that the Toll-like receptor (TLR) system is involved in the early in vivo clonal selection of B-1 cells responsible for natural auto-immunity, which may provide a protective function to ameliorate or even prevent the progression of autoimmune pathology. In part, our hypothesis is based on observations recently made in hyperlipidemic atherosclerosis-prone mice, in which the induction of protective B-1 cell derived anti-phospholipid antibody responses halted the progression of vascular disease. However, this effect has not previously been examined in murine models of autoimmunity.
In Specific Aim 1, we will examine the interplay between the innate and adaptive immune systems by examining the mechanisms responsible for the emergence of these protective responses. In these studies, we will study MyD88 knockout mice, as well as TLR2, 4 and 9 knockout mice, to evaluate the role of these receptor molecules in the induction of protective natural autoimmune antibody responses.
In Specific Aim 2, we will induce high in vivo levels of protective B- 1 cell derived IgM T 15 antibody in a well-established murine lupus model, NZB/W F1 mice, and assess whether these interventions can slow or even prevent the progression of pathologic autoantibody responses and lupus organ damage.

Agency
National Institute of Health (NIH)
Institute
National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)
Type
Exploratory/Developmental Grants (R21)
Project #
1R21AR050659-01
Application #
6727904
Study Section
Special Emphasis Panel (ZAR1-RJB-A (O1))
Program Officer
Gretz, Elizabeth
Project Start
2003-09-26
Project End
2005-06-30
Budget Start
2003-09-26
Budget End
2004-06-30
Support Year
1
Fiscal Year
2003
Total Cost
$76,000
Indirect Cost
Name
University of California San Diego
Department
Internal Medicine/Medicine
Type
Schools of Medicine
DUNS #
804355790
City
La Jolla
State
CA
Country
United States
Zip Code
92093
Strazza, Marianne; Azoulay-Alfaguter, Inbar; Silverman, Gregg J et al. (2015) T cell chemokine receptor patterns as pathogenic signatures in autoimmunity. Discov Med 19:117-25
Vas, Jaya; Gronwall, Caroline; Marshak-Rothstein, Ann et al. (2012) Natural antibody to apoptotic cell membranes inhibits the proinflammatory properties of lupus autoantibody immune complexes. Arthritis Rheum 64:3388-98
Silverman, Gregg J (2011) Regulatory natural autoantibodies to apoptotic cells: pallbearers and protectors. Arthritis Rheum 63:597-602
Silverman, Gregg J (2010) Regulatory natural autoantibodies to apoptotic cells: Pallbearers and protectors. Arthritis Rheum :
Chen, Yifang; Khanna, Sahil; Goodyear, Carl S et al. (2009) Regulation of dendritic cells and macrophages by an anti-apoptotic cell natural antibody that suppresses TLR responses and inhibits inflammatory arthritis. J Immunol 183:1346-59
Silverman, G J; Srikrishnan, R; Germar, K et al. (2008) Genetic imprinting of autoantibody repertoires in systemic lupus erythematosus patients. Clin Exp Immunol 153:102-16
Silverman, Gregg J; Boyle, David L (2008) Understanding the mechanistic basis in rheumatoid arthritis for clinical response to anti-CD20 therapy: the B-cell roadblock hypothesis. Immunol Rev 223:175-85
Silverman, Gregg J; Khanna, Sahil (2007) B cell modulation in rheumatology. Curr Opin Pharmacol 7:426-33
Goodyear, Carl S; Corr, Maripat; Sugiyama, Fujimi et al. (2007) Cutting Edge: Bim is required for superantigen-mediated B cell death. J Immunol 178:2636-40
Goodyear, Carl S; Sugiyama, Fujimi; Silverman, Gregg J (2006) Temporal and dose-dependent relationships between in vivo B cell receptor-targeted proliferation and deletion-induced by a microbial B cell toxin. J Immunol 176:2262-71

Showing the most recent 10 out of 14 publications